Form 4 for ALAB Astera Labs, Inc.
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-25 · accession 0001736297-24-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-11-27 | 2024-11-25 | ALAB | Mohan Jitendra | CEO, Dir | S - Sale | $110.12 | -173.4K | 4.44M | -4% | -$19.09M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-25 | S | D | 28,892 | $110.12 | 850,000 | I By Trust | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F8) These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2024-11-25 | S | D | 28,895 | $110.12 | 600,000 | I By 2022 Trust 2 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F7) These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 3 | Common | Common Stock | 2024-11-25 | S | D | 28,895 | $110.12 | 600,000 | I By 2022 Trust 1 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F6) These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 4 | Common | Common Stock | 2024-11-25 | S | D | 28,895 | $110.12 | 850,000 | I By 2021 Trust 2 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F5) These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 5 | Common | Common Stock | 2024-11-25 | S | D | 28,894 | $110.12 | 850,000 | I By 2021 Trust 1 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F4) These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 6 | Common | Common Stock | 2024-11-25 | S | D | 28,895 | $110.12 | 4,442,603 | I By Living Trust | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions in bulk at prices ranging from $110.0000 to $110.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |